Quarterly ResultMay 11, 2026, 04:38 PM
HARROW Q1 Revenue $44.2M; Net Loss $(27.6M) vs $(17.8M) YoY
AI Summary
HARROW, INC. reported a net loss of $(27.6) million for Q1 2026, a significant increase from $(17.8) million in Q1 2025, with diluted net loss per share rising to $(0.74) from $(0.50). Total revenues decreased to $44.2 million from $47.8 million year-over-year. The company also saw a substantial increase in cash used in investing activities, primarily due to $18 million in product rights acquisitions, and raised $49 million from 8.625% notes payable.
Key Highlights
- Q1 2026 total revenues decreased to $44.2 million from $47.8 million in Q1 2025.
- Net loss for Q1 2026 increased to $(27.6) million from $(17.8) million in Q1 2025.
- Diluted net loss per share was $(0.74) in Q1 2026, compared to $(0.50) in Q1 2025.
- Cash and cash equivalents increased to $94.6 million at March 31, 2026, from $72.9 million at December 31, 2025.
- Net cash used in operating activities was $(8.99) million in Q1 2026, a shift from $19.67 million provided in Q1 2025.
- Net cash provided by financing activities was $48.9 million, including $49 million from 8.625% notes payable.
- Acquired product rights totaled $18 million, including payments for Santen, Samsung Bioepis, and VEVYE milestones.
- Total stockholders' equity decreased to $28.35 million from $52.09 million at December 31, 2025.
Price Impact
More from HROW